Multicenter, Double-Blind, Placebo-Controlled, Randomized Phase II Trial of Gemcitabine/Cisplatin Plus Bevacizumab or Placebo in Patients With Malignant Mesothelioma - Concepedia

Concepedia

Publication | Open Access

Multicenter, Double-Blind, Placebo-Controlled, Randomized Phase II Trial of Gemcitabine/Cisplatin Plus Bevacizumab or Placebo in Patients With Malignant Mesothelioma

DOI Full Paper Access

256

Citations

35

References

2012

Year

Hedy L. Kindler, Theodore Karrison, David R. Gandara, Charles Lu, Lee M. Krug, James Stevenson, Pasi A. Jänne, David I. Quinn, Marianna Koczywas, Julie R. Brahmer,

Journal of Clinical Oncology

Abstract

The addition of bevacizumab to gemcitabine/cisplatin in this trial did not significantly improve PFS or OS in patients with advanced MM.

References

	Year	Citations

Page 1